Safe use of capecitabine-cisplatin in metastatic gastric carcinoma with severe liver dysfunction: a case report from Algeria.

about

Safe use of capecitabine-cisplatin in metastatic gastric carcinoma with severe liver dysfunction: a case report from Algeria.

Item

http://www.wikidata.org/entity/Q42364212

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Safe use of capecitabine-cispl ...... n: a case report from Algeria.

@en

Safe use of capecitabine-cispl ...... n: a case report from Algeria.

@nl

type

Item

label

Safe use of capecitabine-cispl ...... n: a case report from Algeria.

@en

Safe use of capecitabine-cispl ...... n: a case report from Algeria.

@nl

prefLabel

Safe use of capecitabine-cispl ...... n: a case report from Algeria.

@en

Safe use of capecitabine-cispl ...... n: a case report from Algeria.

@nl

P1476

Safe use of capecitabine-cispl ...... n: a case report from Algeria.

@en

P2093

Boudali Bouchra

http://www.w3.org/2001/XMLSchema#string

Ghomari Soumia

http://www.w3.org/2001/XMLSchema#string

Lasgaa Meryem

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunction.

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

Surgical treatment of liver metastases.

Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature.

Capecitabine and oxaliplatin (XELOX) for the treatment of patients with metastatic gastric cancer and severe liver dysfunction

Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy.

Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

P304

4942-4945

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.19082/4942

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28979726

http://www.w3.org/2001/XMLSchema#string

P921

Algeria

P932

5614276

http://www.w3.org/2001/XMLSchema#string